Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
D000367:Age Factors; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009438:Neuraminic Acids / Q000134:cerebrospinal fluid*; D010300:Parkinson Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D010301:Parkinson Disease, Postencephalitic / Q000134:cerebrospinal fluid / Q000188:drug therapy; D013997:Time Factors
D009438:Neuraminic Acids; D004295:Dihydroxyphenylalanine